Robert Rintoul, BSc, MB ChB, PhD, FRCP, discusses the importance of minimal residual disease assessment in patients with non–small cell lung cancer.
Robert Rintoul, BSc, MB ChB, MRCP, PhD, FRCP
Advertisement
Articles by Robert Rintoul, BSc, MB ChB, MRCP, PhD, FRCP
Advertisement
Latest Updated Articles
Dr. Rintoul on the Importance of MRD Assessment in NSCLCPublished: June 22nd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
2
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma
5